RANBAXY SET TO MAKE LARGE QUANTITY OF TAMIFLU

A A

Indian generic drug company Ranbaxy Laboratories Ltd. said on Thursday that it was prepared to produce large quantities of Tamiflu for the United States to help meet the threat of avian flu and was in talks with the drug's maker, Roche Holding AG. Ranbaxy said within a year it could provide enough oseltamivir phosphate -- the active ingredient in Tamiflu -- to produce 1.3 billion 75 milligram capsules. Within six months of beginning production, Ranbaxy believes it can produce 300 million capsules.

Reuters UK (http://today.reuters.co.uk/news/newsArticle.aspx?type=globalNews&storyID=2005-12-01T175313Z_01_YUE161975_RTRUKOC_0_US-BIRDFLU-RANBAXY.xml&archived=False)